Aclaris Therapeutics Inc (ACRS) Insider Trading
- $53,972,242.89
- $87,229,203.38
- July 30, 2024
- Braden Michael Leonard
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 23, 2018 | Director | 6,600 | $15.00 | Buy | $99,000.00 | |
| Aug. 15, 2018 | Director | 6,250 | $15.97 | Buy | $99,812.50 | |
| June 12, 2018 | Insider | 5,000 | $20.00 | Sell | $100,000.00 | |
| May 18, 2018 | Insider | 10,000 | $20.00 | Sell | $200,000.00 | |
| May 16, 2018 | Director | 500 | $19.12 | Buy | $9,560.00 | |
| May 7, 2018 | CFO | 1,250 | $18.22 | Buy | $22,775.00 | |
| April 6, 2018 | CFO | 1,250 | $16.59 | Buy | $20,737.50 | |
| April 6, 2018 | Director | 26,700 | $16.54 | Buy | $441,618.00 | |
| April 5, 2018 | Insider | 10,000 | $16.75 | Buy | $167,500.00 | |
| Aug. 16, 2017 | Director | 108,601 | $23.02 | Buy | $2,499,995.02 | |
| March 2, 2017 | Major Shareholder | 425,000 | $30.82 | Sell | $13,098,500.00 | |
| Jan. 10, 2017 | Director | 750,000 | $28.25 | Sell | $21,187,500.00 | |
| Nov. 18, 2016 | Major Shareholder | 907,828 | $23.03 | Sell | $20,907,278.84 | |
| Oct. 26, 2016 | Insider | 3,912 | $21.83 | Sell | $85,398.96 | |
| Sept. 28, 2016 | Insider | 1,841 | $24.66 | Sell | $45,399.06 | |
| Sept. 16, 2016 | Major Shareholder | 525,550 | $24.19 | Sell | $12,713,054.50 | |
| Aug. 26, 2016 | Insider | 3,738 | $20.35 | Sell | $76,068.30 | |
| Feb. 23, 2016 | Major Shareholder | 39,726 | $17.15 | Buy | $681,300.90 | |
| Jan. 20, 2016 | Major Shareholder | 7,803 | $19.87 | Buy | $155,045.61 | |
| Jan. 13, 2016 | Major Shareholder | 15,637 | $19.10 | Buy | $298,666.70 | |
| Oct. 29, 2015 | Major Shareholder | 244,200 | $14.00 | Buy | $3,418,800.00 | |
| Oct. 22, 2015 | Major Shareholder | 5,410 | $14.03 | Buy | $75,902.30 | |
| Oct. 21, 2015 | Major Shareholder | 34,999 | $14.89 | Buy | $521,135.11 | |
| Oct. 14, 2015 | Major Shareholder | 42,813 | $14.06 | Buy | $601,950.78 | |
| Oct. 13, 2015 | Insider | 335,455 | $11.00 | Buy | $3,690,005.00 | |
| Oct. 13, 2015 | Director | 454,545 | $11.00 | Buy | $4,999,995.00 | |
| Oct. 13, 2015 | Major Shareholder | 409,090 | $11.00 | Buy | $4,499,990.00 | |
| Oct. 8, 2015 | Major Shareholder | 2,237,130 | $10.86 | Buy | $24,295,231.80 | |
| Oct. 7, 2015 | Major Shareholder | 13,352 | $11.00 | Buy | $146,872.00 |
Insiders are both buying and selling Aclaris Therapeutics Inc stock.
The insider traders at Aclaris Therapeutics Inc are: Braden Michael Leonard, Kamil Ali-Jackson, Ra Capital Management, Llc, Joseph Monahan, Neal Walker, Andrew N Schiff, Frank Ruffo, James E Flynn, Stephen A Tullman, James Loerop, Ventures Fund Vii L.P. Vivo, Anand Mehra, David N Gordon, Vivo Ventures Vii, Llc, Andrew Kenneth William Powell, Andrew N. Schiff, Douglas J Manion, Fmr Llc, Kevin Balthaser, Sofinnova Venture Partners Vii, and Albert Cha
The most active insider trader at Aclaris Therapeutics Inc is Braden Michael Leonard with 10 trades.
Ventures Fund Vii L.P. Vivo has sold the most Aclaris Therapeutics Inc stock with a total value of $47,104,278.84.
Ra Capital Management, Llc has bought the most Aclaris Therapeutics Inc stock with a total value of $30,729,334.10.
The most recent insider trade for Aclaris Therapeutics Inc was on July 30, 2024.
The single biggest insider buy for Aclaris Therapeutics Inc was from Ra Capital Management, Llc with a total value of $24,295,231.80 on Oct. 8, 2015.
The single biggest insider sell for Aclaris Therapeutics Inc was from Anand Mehra with a total value of $21,187,500.00 on Jan. 10, 2017.